A61K 39 - Medicinal preparations containing antigens or antibodies

Patents for A61K 39 - Medicinal preparations containing antigens or antibodies (182,248)
10/2007
10/18/2007	US20070243204 Helicobacter pylori proteins useful for vaccines and diagnostics
10/18/2007	US20070243203 HIV polypeptide and polynucleotide fusions of Gag, Pol and Nef; AIDS; purifying the fusion polypeptide; carboxyamidation
10/18/2007	US20070243202 Tumor necrosis factor receptor-associated factors
10/18/2007	US20070243201 Method for Selecting Epitopes for Immunotherapy
10/18/2007	US20070243200 Trehalose producing cells as vaccines
10/18/2007	US20070243199 Methods and compositions for vaccination of poultry
10/18/2007	US20070243198 Production of biologically active proteins
10/18/2007	US20070243197 Dendrite Cells Transduced with Recombinant Adenovirus Advcea Which Generate Cea-Specific Cytotoxic T Lymphocytes, Vaccine and Pharmaceutical Composition Comprising the Same
10/18/2007	US20070243196 Mage-3 and NY-ESO-1 Based Polyvalent Vaccine for Cancer Immunotherapy
10/18/2007	US20070243195 Vaccine against streptococci
10/18/2007	US20070243194 Anti-IGF-1R antibodies and uses thereof
10/18/2007	US20070243193 Compositions and methods for the diagnosis and treatment of tumor
10/18/2007	US20070243192 Growth hormone receptor antagonist cancer treatment
10/18/2007	US20070243191 Anti-hyperproliferative therapies targeting hdgf
10/18/2007	US20070243190 Receptor-mediated uptake of an extracellular bcl-xl fusion protein inhibits apoptosis
10/18/2007	US20070243189 Blood VEGF level-lowering agent containing IL-6 antagonist as the active ingredient
10/18/2007	US20070243188 Fc Variants Having Decreased Affinity for FcyRlla
10/18/2007	US20070243187 Methods and Materials for Treating Autoimmune Diseases and Conditions
10/18/2007	US20070243186 ISLR gene and its association with osteoarthritis and other bone and cartilage disorders, expression products derived therefrom, and uses thereof
10/18/2007	US20070243185 Suitable for long-term storage of polypeptides containing an Fc domain of an immunoglobulin; containing polypeptide with an aggregation inhibitor selected from the group consisting of L-arginine and L-cysteine.
10/18/2007	US20070243184 Prophylaxis and treatment of enterocolitis associated with anti-ctla-4 antibody therapy
10/18/2007	US20070243162 Labeled monoclonal antibody binds Kaposi's sarcoma-associated herpesvirus (KSHV); use in diagnosis and prognosis
10/18/2007	US20070243161 Epigenetic modification of the loci for CAMTA1 and/or FOXP3 as a marker for cancer treatment
10/18/2007	US20070243159 Therapeutic Compositions and Vaccines By Glycosyl-Phosphatidylinositol (Gpi)-Anchored Cytokines and Immunostimulatory Molecules
10/18/2007	US20070243137 Cell and sub-cell methods for imaging and therapy
10/18/2007	US20070243132 Transdermal delivery of pharmaceutical agents
10/18/2007	DE10045123B4 Das C. albicans TEC1 GEN(CaTEC1) und das kodierte Tec1p Protein The C. albicans TEC1 GEN (CaTEC1) and the encoded protein Tec1p
10/18/2007	CA2849203A1 Glycosylated antibodies
10/18/2007	CA2651911A1 Anti ku70 internalizing antibodies
10/18/2007	CA2648846A1 Antibody compositions and methods for treatment of neoplastic disease
10/18/2007	CA2648644A1 Muscle regeneration promoter
10/18/2007	CA2648629A1 Marker for predicting graft-versus-host disease and utilization of the same
10/18/2007	CA2648593A1 Streptococcus pneumoniae conjugate vaccines
10/18/2007	CA2648585A1 Stabilized immune modulatory rna (simra) compounds for tlr7 and tlr8
10/18/2007	CA2648582A1 Conjugates of an anti-tnf-alpha antibody
10/18/2007	CA2648459A1 Compositions and methods for the analysis and treatment of aids wasting syndrome and immune cell dysfunction
10/18/2007	CA2648407A1 Compositions and methods for treating polycystic kidney disease
10/18/2007	CA2648330A1 Anti-ccr2 antibody depletes monocytes to treat multiple sclerosis and rheumatoid arthritis
10/18/2007	CA2648284A1 Antibodies that bind human protein tyrosine phosphatase beta (hptpbeta) and uses thereof
10/18/2007	CA2648188A1 Methods for treating conditions associated with masp-2 dependent complement activation
10/18/2007	CA2647524A1 Polypeptides with enhanced anti-inflammatory and decreased cytotoxic properties and relating methods
10/18/2007	CA2647288A1 Glycosylated antibodies
10/18/2007	CA2647029A1 Antibody purification
10/18/2007	CA2646900A1 Hypoallergenic chimeric proteins belonging to the lipid transfer family of parietaria judaica for use in the treatment of allergies
10/18/2007	CA2643633A1 The use of an antibody directed against beta amyloid peptide for the treatment of alzheimer's disease
10/18/2007	CA2642632A1 Immunoglobulins from vitiligo plasma for melanoma therapy
10/18/2007	CA2638774A1 Transgenic animals expressing chimeric antibodies for use in preparing human antibodies
10/18/2007	CA2627952A1 Combination vaccine comprising an attenuated bovine viral diarrhea virus
10/17/2007	EP1845164A2 Promoters for expression in modified vaccinia virus ankara
10/17/2007	EP1845108A2 Monoclonal antibodies to purified hepatitis c virus envelope proteins for diagnostic and therapeutic use
10/17/2007	EP1844815A1 Combination therapy comprising anti-CD20 and anti-CD40 antibodies for the treatment of B cell-related cancers
10/17/2007	EP1844791A1 Improved modified live BRSV vaccine
10/17/2007	EP1844790A2 Using a reverse genetic engineering platform to produce protein vaccinces and protein vaccine of avian influenza virus
10/17/2007	EP1844789A1 Emulsified composition for dilution and cancer vaccine composition
10/17/2007	EP1844788A1 HER-2/neu multi-peptide vaccine
10/17/2007	EP1844337A1 Binding compounds, immunogenic compounds and peptidomimetics
10/17/2007	EP1844336A1 Immunoregulation in cancer, chronic inflammatory and autoimmune diseases
10/17/2007	EP1844077A2 Dr5 antibodies and uses thereof
10/17/2007	EP1844069A1 Molecules and chimeric molecules thereof
10/17/2007	EP1843811A2 Coated microprojections having reduced variability and method for producing same
10/17/2007	EP1843789A2 Compositions and methods for treating fibrotic disorders
10/17/2007	EP1843787A2 Lipid and nitrous oxide combination as adjuvant for the enhancement of the efficacy of vaccines
10/17/2007	EP1843786A2 Dcchol for newborns
10/17/2007	EP1843785A2 Polypeptides for inducing a protective immune response against staphylococcus aureus
10/17/2007	EP1417487B1 Epitope testing using hla
10/17/2007	EP1416916B1 Chitin microparticles and their medical uses
10/17/2007	EP1311289B1 Vaccines containing ribavirin
10/17/2007	EP1294892B1 Assembly of wild-type and chimeric influenza virus-like particles (vlps)
10/17/2007	EP1276770B1 Proteins with a high immunoreactivity and a method for the production thereof
10/17/2007	EP1154686B1 Method for inhibiting transplant rejection
10/17/2007	EP1144006B1 CCR5 Antibody PA14
10/17/2007	EP1123387B1 Mn gene and protein
10/17/2007	EP1093818B9 Powdery preparation for mucosal administration containing polymeric medicine
10/17/2007	EP1092018B1 Kv6.2, A VOLTAGE-GATED POTASSIUM CHANNEL SUBUNIT
10/17/2007	EP1076710B1 Factors affecting tumor necrosis factor receptor releasing enzyme activity
10/17/2007	EP1075276B1 Adjuvant composition and methods for its use
10/17/2007	CN101056982A Mutant porcine reproductive and respiratory syndrome virus
10/17/2007	CN101056979A Anti-histone H1 monoclonal antibody and hybridoma capable of producing the same
10/17/2007	CN101056977A Subtype-matched inactivated whole virus vaccines for treating patients with HIV infection
10/17/2007	CN101056976A Defective influenza virus particles
10/17/2007	CN101056655A Methods of treating CD30 positive lymphomas
10/17/2007	CN101056654A Type i interferon blocking agents for prevention and treatment of psoriasis
10/17/2007	CN101056653A Vaccines comprising plasmodium antigens
10/17/2007	CN101056651A Method of enhancing the immune response to a vaccine
10/17/2007	CN101056613A Controlled and directed local delivery of anti-inflammatory compositions
10/17/2007	CN101054582A A-type kreotoxin receptor combination region Hc, coding protein and application thereof
10/17/2007	CN101054417A Recombinant antibodies related to ganglioside and its application in diagnosing and treating tumor
10/17/2007	CN101054416A HAb18GC2 monoclonal antibody and its light and heavy chain variable area genes, coding polypeptide and use
10/17/2007	CN101054415A Humanized single chain antibody for anti-human cytomegalovirus envelope glycoprotein
10/17/2007	CN101053658A H3 and H9 subtype influenza composite multiepitope bivalent DNA vaccine
10/17/2007	CN100343393C Central airway administration for systemic delivery of therapeutics
10/17/2007	CN100343280C CUDR as biomarker for cancer progression and therapeutic response
10/17/2007	CN100342911C Bivalent DNA vaccine of type A and type O foot-and-mouth disease virus and its preparing process
10/16/2007	US7282590 Drug conjugates
10/16/2007	US7282578 Having at least one intron sequence; constructs and host cells; expression product and antibodies obtainable by immunization of an animal therewith, as well as the use of antibodies in screening methods for the identification of tumors
10/16/2007	US7282577 Nucleotide sequences coding hemolytic protein for use tool in treatment of jelly fish stings
10/16/2007	US7282570 Nucleotide sequences for use in the treatment and diagnosis of immunological and inflammatory disorders
10/16/2007	US7282568 Human monoclonal antibodies against interleukin 8 (IL-8)
10/16/2007	US7282562 Invention is based on identification of proteins (including agonist and antagonist antibodies) which either stimulate or inhibit immune response in mammals; immune related diseases can be treated by suppressing or enhancing immune response
10/16/2007	US7282490 Osteopontin-related compositions and methods

1 ... 815 816 817 818 819 820 821 822 823 824 825 826 827 828 829 830 831 832 833 834 835 ... 1823